Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Net Income (2016 - 2025)

Marimed (MRMD) has disclosed Net Income for 15 consecutive years, with -$4.6 million as the latest value for Q4 2025.

  • Quarterly Net Income rose 43.84% to -$4.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$14.3 million through Dec 2025, down 17.13% year-over-year, with the annual reading at -$14.5 million for FY2025, 16.3% down from the prior year.
  • Net Income for Q4 2025 was -$4.6 million at Marimed, down from -$2.9 million in the prior quarter.
  • The five-year high for Net Income was $7.6 million in Q2 2021, with the low at -$10.1 million in Q4 2023.
  • Average Net Income over 5 years is -$1.1 million, with a median of -$1.1 million recorded in 2024.
  • The sharpest move saw Net Income soared 764.98% in 2021, then crashed 319.5% in 2025.
  • Over 5 years, Net Income stood at -$6.4 million in 2021, then skyrocketed by 174.23% to $4.7 million in 2022, then tumbled by 313.27% to -$10.1 million in 2023, then grew by 18.4% to -$8.3 million in 2024, then surged by 43.84% to -$4.6 million in 2025.
  • According to Business Quant data, Net Income over the past three periods came in at -$4.6 million, -$2.9 million, and -$1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.